A prescription of a NOAC within 90 days prior to hospitalization or outpatient clinic visit for VTE.
Patients with NOAC preference apart from preference consistent with current cluster randomized NOAC.
Other contraindications mentioned in the "Summary of Product Characteristics" for the respective NOAC.

NCT03129555_exc_T1
Drug
NOAC
NCT03129555_exc_T2
Temporal
within 90 days prior to hospitalization or outpatient clinic visit for VTE
NCT03129555_exc_T5
Condition
VTE
NCT03129555_exc_T3
Reference_point
hospitalization or outpatient clinic visit for VTE
NCT03129555_exc_T4
Procedure
hospitalization
NCT03129555_exc_T6
Procedure
outpatient clinic visit
NCT03129555_exc_T7
Visit
outpatient clinic
NCT03129555_exc_T8
Visit
hospitalization
NCT03129555_exc_T9
Scope
hospitalization or outpatient clinic visit for VTE
NCT03129555_exc_T10
Drug
NOAC
NCT03129555_exc_T11
Observation
NOAC preference
NCT03129555_exc_T13
Condition
contraindications
NCT03129555_exc_T14
Qualifier
Other
NCT03129555_exc_T15
Qualifier
Summary of Product Characteristics
NCT03129555_exc_T16
Drug
NOAC